Involvement of 5-hydroxytryptamine neuronal system in Δ9-tetrahydrocannabinol-induced impairment of spatial memory

被引:65
作者
Egashira, N
Mishima, K
Katsurabayashi, S
Yoshitake, T
Matsumoto, Y
Ishida, J
Yamaguchi, M
Iwasaki, K
Fujiwara, M [1 ]
机构
[1] Fukuoka Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Fukuoka 8140180, Japan
[3] Chem Inspect & Testing Inst, Chem Biotesting Ctr, Oita, Japan
[4] Kyushu Womens Jr Coll, Sch Nursing, Kitakyushu, Fukuoka 8078586, Japan
关键词
Delta(9)-tetrahydrocannabinol; 5-HT; (5-hydroxytryptamine; serotonin); hippocampus; spatial memory; DOI (I -(2,5-dimethoxy 4-iodophenyl)-2-amino; propane);
D O I
10.1016/S0014-2999(02)01755-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study investigated the involvement of the serotonin (5-hydroxytryptamine, 5-HT) neuronal system in the Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory in the eight-ann radial maze in rats. Delta(9)-Tetrahydrocannabinol (6 mg/kg, i.p.), which impairs spatial memory, significantly increased the 5-HT content in the ventral hippocampus. A microdialysis study showed that Delta(9)-tetrahydrocannabinol (6 mg/kg, i.p.) decreased 5-HT release in the ventral hippocampus. The 5-HT precursor, 5-hydroxy-L-tryptophan (5-HTP 50 mg/kg, i.p.), the 5-HT re-uptake inhibitor, clomipramine (0.01 and 0.1 mg/kg, i.p.), the 5-HT receptor agonist, 5-methoxy-N,N-dimethyltryptamine (5-MeODMT; 0.01 and 0.03 mg/kg, i.p.), and the 5-HT2 receptor agonist, 1-(2,5-dimethoxy 4-iodophenyl)-2-amino propane (DOI; 10 mug/kg, i.p.), significantly attenuated the Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. These results suggest that the 5-HT neuronal system may be involved in the Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:221 / 229
页数:9
相关论文
共 59 条
[1]   Δ9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo:: a microdialysis study [J].
Acquas, E ;
Pisanu, A ;
Marrocu, P ;
Goldberg, SR ;
Di Chiara, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 419 (2-3) :155-161
[2]   DIFFERENTIAL INHIBITION OF SEROTONIN RELEASE BY 5-HT AND NA REUPTAKE BLOCKERS AFTER SYSTEMIC ADMINISTRATION [J].
AUERBACH, SB ;
LUNDBERG, JF ;
HJORTH, S .
NEUROPHARMACOLOGY, 1995, 34 (01) :89-96
[3]   AUTORADIOGRAPHIC ANALYSIS OF DIFFERENTIAL ASCENDING PROJECTIONS OF DORSAL AND MEDIAN RAPHE NUCLEI IN RAT [J].
AZMITIA, EC ;
SEGAL, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 179 (03) :641-667
[4]   Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides [J].
Barg, J ;
Fride, E ;
Hanus, L ;
Levy, R ;
MatusLeibovitch, N ;
Heldman, E ;
Bayewitch, M ;
Mechoulam, R ;
Vogel, Z .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 287 (02) :145-152
[5]   SEROTONIN RELEASE ESTIMATED BY TRANSCORTICAL DIALYSIS IN FREELY-MOVING RATS [J].
CARBONI, E ;
DICHIARA, G .
NEUROSCIENCE, 1989, 32 (03) :637-645
[6]   Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT1A receptors in the dorsal raphe [J].
Carli, M ;
Balducci, C ;
Samanin, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (02) :375-381
[7]   Inhibition of hippocampal acetylcholine release after acute and repeated Δ9-tetrahydrocannabinol in rats [J].
Carta, G ;
Nava, F ;
Gessa, GL .
BRAIN RESEARCH, 1998, 809 (01) :1-4
[8]   5-HT1A RECEPTOR AGONISTS IMPROVE THE PERFORMANCE OF NORMAL AND SCOPOLAMINE-IMPAIRED RATS IN AN OPERANT DELAYED MATCHING TO POSITION TASK [J].
COLE, BJ ;
JONES, GH ;
TURNER, JD .
PSYCHOPHARMACOLOGY, 1994, 116 (02) :135-142
[9]   DO FUNCTIONAL-RELATIONSHIPS EXIST BETWEEN 5-HT1A AND 5-HT2 RECEPTORS [J].
DARMANI, NA ;
MARTIN, BR ;
PANDEY, U ;
GLENNON, RA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) :901-906
[10]   Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice [J].
Darmani, NA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 68 (02) :311-317